CR6983A - HISTAMINE RECEIVER ANTAGONISTS - Google Patents
HISTAMINE RECEIVER ANTAGONISTSInfo
- Publication number
- CR6983A CR6983A CR6983A CR6983A CR6983A CR 6983 A CR6983 A CR 6983A CR 6983 A CR6983 A CR 6983A CR 6983 A CR6983 A CR 6983A CR 6983 A CR6983 A CR 6983A
- Authority
- CR
- Costa Rica
- Prior art keywords
- histamine
- receiver
- histamine receiver
- receiver antagonists
- antagonists
- Prior art date
Links
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 title abstract 12
- 229960001340 histamine Drugs 0.000 title abstract 6
- 239000005557 antagonist Substances 0.000 title abstract 3
- OVBICQMTCPFEBS-SATRDZAXSA-N (2s)-1-[(2s)-2-[[(2s)-2-[[(2r)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-[bi Chemical compound CC(O)=O.CC(O)=O.C([C@@H](C(=O)N[C@H](CCCCN=C(NCC)NCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C)C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC=1C=NC=CC=1)NC(=O)[C@@H](CC=1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(C)=O)C1=CC=C(O)C=C1 OVBICQMTCPFEBS-SATRDZAXSA-N 0.000 abstract 1
- 108700032141 ganirelix Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA UNA COMBINACION DE (A) UN ANTAGONISTA DE RECEPTOR H1 DE HISTAMINA Y (B) UN ANTAGONISTA QUE ES AL MENOS 10 VECES MAS SELECTIVO PARA EL RECEPTOR H4 DE HISTAMINA EN COMPARACION CON EL RECEPTOR H3 DE HISTAMINA, Y UN ANTAGONISTA QUE ES AL MENOS 10 VECES MAS SELECTIVO PARA EL RECEPTOR H4 DE HISTAMINA EN COMPARACION CON EL RECEPTOR H3 DE HISTAMINA Y SUS COMPOSICIONES Y USOS.THIS INVENTION PROVIDES A COMBINATION OF (A) AN HISTAMINE RECEIVER ANTAGONIST AND (B) AN ANTAGONIST THAT IS AT LEAST 10 TIMES MORE SELECTIVE FOR HISTAMINE RECEIVER H4, COMPARED TO HISTAMINE RECEIVER, AND AN ANTAGON IT IS AT LEAST 10 TIMES MORE SELECTIVE FOR THE H4 HISTAMINE RECEIVER COMPARED TO THE HISTAMINE H3 RECEIVER AND ITS COMPOSITIONS AND USES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0101223.6A GB0101223D0 (en) | 2001-01-17 | 2001-01-17 | Histamine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR6983A true CR6983A (en) | 2003-11-25 |
Family
ID=9906993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR6983A CR6983A (en) | 2001-01-17 | 2003-05-22 | HISTAMINE RECEIVER ANTAGONISTS |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1353657A1 (en) |
| JP (1) | JP2004517883A (en) |
| KR (1) | KR20030069216A (en) |
| CN (1) | CN1486178A (en) |
| AP (1) | AP2002002401A0 (en) |
| AR (1) | AR032101A1 (en) |
| BG (1) | BG107834A (en) |
| BR (1) | BR0206502A (en) |
| CA (1) | CA2435121A1 (en) |
| CR (1) | CR6983A (en) |
| CZ (1) | CZ20031853A3 (en) |
| DO (1) | DOP2002000325A (en) |
| EA (1) | EA200300537A1 (en) |
| EC (1) | ECSP034692A (en) |
| EE (1) | EE200300335A (en) |
| GB (1) | GB0101223D0 (en) |
| GT (1) | GT200200003A (en) |
| HU (1) | HUP0302767A2 (en) |
| IL (1) | IL156087A0 (en) |
| IS (1) | IS6818A (en) |
| MA (1) | MA26980A1 (en) |
| MX (1) | MXPA03006408A (en) |
| NO (1) | NO20033223D0 (en) |
| OA (1) | OA12440A (en) |
| PA (1) | PA8537101A1 (en) |
| PL (1) | PL362793A1 (en) |
| SK (1) | SK8572003A3 (en) |
| SV (1) | SV2003000849A (en) |
| TN (1) | TNSN02003A1 (en) |
| WO (1) | WO2002056871A2 (en) |
| ZA (1) | ZA200304180B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030133931A1 (en) * | 2001-12-21 | 2003-07-17 | Robin Thurmond | Use of histamine H4 receptor antagonist for the treatment of inflammatory responses |
| AU2003265961A1 (en) * | 2002-09-06 | 2004-03-29 | Janssen Pharmaceutica N.V. | Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| WO2004066960A2 (en) * | 2003-01-28 | 2004-08-12 | Schering Corporation | Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| US8236786B2 (en) * | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| CN104582703A (en) | 2012-06-08 | 2015-04-29 | 森索睿翁公司 | H4 receptor inhibitors for treating tinnitus |
-
2001
- 2001-01-17 GB GBGB0101223.6A patent/GB0101223D0/en not_active Ceased
-
2002
- 2002-01-10 SK SK857-2003A patent/SK8572003A3/en unknown
- 2002-01-10 BR BR0206502-9A patent/BR0206502A/en not_active IP Right Cessation
- 2002-01-10 EP EP02732099A patent/EP1353657A1/en not_active Withdrawn
- 2002-01-10 OA OA1200300174A patent/OA12440A/en unknown
- 2002-01-10 PL PL02362793A patent/PL362793A1/en not_active Application Discontinuation
- 2002-01-10 EE EEP200300335A patent/EE200300335A/en unknown
- 2002-01-10 IL IL15608702A patent/IL156087A0/en unknown
- 2002-01-10 CZ CZ20031853A patent/CZ20031853A3/en unknown
- 2002-01-10 MX MXPA03006408A patent/MXPA03006408A/en unknown
- 2002-01-10 JP JP2002557379A patent/JP2004517883A/en not_active Withdrawn
- 2002-01-10 EA EA200300537A patent/EA200300537A1/en unknown
- 2002-01-10 CA CA002435121A patent/CA2435121A1/en not_active Abandoned
- 2002-01-10 WO PCT/IB2002/000042 patent/WO2002056871A2/en not_active Application Discontinuation
- 2002-01-10 CN CNA028036840A patent/CN1486178A/en active Pending
- 2002-01-10 HU HU0302767A patent/HUP0302767A2/en unknown
- 2002-01-10 KR KR10-2003-7009493A patent/KR20030069216A/en not_active Application Discontinuation
- 2002-01-11 DO DO2002000325A patent/DOP2002000325A/en unknown
- 2002-01-14 PA PA20028537101A patent/PA8537101A1/en unknown
- 2002-01-16 GT GT200200003A patent/GT200200003A/en unknown
- 2002-01-16 SV SV2002000849A patent/SV2003000849A/en not_active Application Discontinuation
- 2002-01-16 TN TNTNSN02003A patent/TNSN02003A1/en unknown
- 2002-01-16 AR ARP020100145A patent/AR032101A1/en not_active Application Discontinuation
- 2002-01-17 AP APAP/P/2002/002401A patent/AP2002002401A0/en unknown
-
2003
- 2003-05-15 IS IS6818A patent/IS6818A/en unknown
- 2003-05-21 BG BG107834A patent/BG107834A/en unknown
- 2003-05-22 CR CR6983A patent/CR6983A/en not_active Application Discontinuation
- 2003-05-29 ZA ZA200304180A patent/ZA200304180B/en unknown
- 2003-07-11 MA MA27233A patent/MA26980A1/en unknown
- 2003-07-16 NO NO20033223A patent/NO20033223D0/en not_active Application Discontinuation
- 2003-07-17 EC EC2003004692A patent/ECSP034692A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK8572003A3 (en) | 2004-07-07 |
| IS6818A (en) | 2003-05-15 |
| AP2002002401A0 (en) | 2002-03-31 |
| KR20030069216A (en) | 2003-08-25 |
| MXPA03006408A (en) | 2003-10-15 |
| ZA200304180B (en) | 2004-06-15 |
| NO20033223L (en) | 2003-07-16 |
| GT200200003A (en) | 2002-08-19 |
| CN1486178A (en) | 2004-03-31 |
| JP2004517883A (en) | 2004-06-17 |
| BG107834A (en) | 2004-01-30 |
| ECSP034692A (en) | 2003-08-29 |
| AR032101A1 (en) | 2003-10-22 |
| PA8537101A1 (en) | 2002-08-29 |
| CA2435121A1 (en) | 2002-07-25 |
| EE200300335A (en) | 2003-12-15 |
| TNSN02003A1 (en) | 2005-12-23 |
| EA200300537A1 (en) | 2004-02-26 |
| NO20033223D0 (en) | 2003-07-16 |
| OA12440A (en) | 2006-05-22 |
| CZ20031853A3 (en) | 2004-07-14 |
| GB0101223D0 (en) | 2001-02-28 |
| EP1353657A1 (en) | 2003-10-22 |
| DOP2002000325A (en) | 2003-01-31 |
| WO2002056871A2 (en) | 2002-07-25 |
| HUP0302767A2 (en) | 2003-11-28 |
| BR0206502A (en) | 2003-10-21 |
| SV2003000849A (en) | 2003-01-13 |
| IL156087A0 (en) | 2003-12-23 |
| PL362793A1 (en) | 2004-11-02 |
| MA26980A1 (en) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8567001A1 (en) | ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS | |
| PA8527201A1 (en) | CYCLED PEPTIDES WITH AGONIST ACTIVITY FOR THE RECEIVER OF MELANOCORTIN-4 (MC4-R) | |
| DK1328269T3 (en) | Combination of a CB1 receptor antagonist and sibutramine for the treatment of obesity | |
| DK1379239T3 (en) | N (2-aryl-ethyl) -benzylamines as antagonists of the HT6 receptor | |
| HN2001000266A (en) | SELECTIVE AGONISTS OF THE EP4 RECEPTOR IN THE TREATMENT OF OSTEOPOROSIS. | |
| PT1300398E (en) | PROCESSES AND COMPOSITIONS FOR CANCER THERAPIES, USING GENES THAT CODE THE BETA INTERFERENCE | |
| CL2004001119A1 (en) | COMPOUNDS DERIVED FROM OXIMAS; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM; AND ITS USE AS USEFUL IMMUNOSUPPRESSORS IN DISEASES MEDIATED BY THE EDG RECEIVER, TALEES AS AUTOIMMUNE, INFLAMMATORY, INFECTIOUS AND CANCER DISEASES. | |
| HN2003000417A (en) | INTERMEDIATE OF ACCEPTABLE NON-HYGROSCOPIC FORMULATION UNDERSTANDING A HYGROSCOPIC PHARMACO | |
| HN2002000299A (en) | DERIVATIVES OF 3- AZABICICLO [3.1.0] HEXANO | |
| NO993350L (en) | Vitronectin receptor antagonists | |
| ATE359279T1 (en) | MUSK ODORS | |
| ECSP055888A (en) | DERIVATIVES OF ARIL-QUINAZOLIN / ARIL-2-AMINO-FENIL METANONA THAT PROMOTE THE RELEASE OF PARTIROID HORMONE. | |
| UY28007A1 (en) | THERAPEUTIC TREATMENT | |
| CR6983A (en) | HISTAMINE RECEIVER ANTAGONISTS | |
| SV2004001250A (en) | MUSCARINIC AGONISTS REF, X - 15335 | |
| UY26627A1 (en) | IL-8 RECEPTOR ANTAGONISTS | |
| SV2003001179A (en) | FORMULATION OF 2-METHYL-TIENO-BENZODIACEPIN LIOFILIZED REF. X-11102 | |
| UY27124A1 (en) | HISTAMINE RECEIVER ANTAGONISTS | |
| DK1177191T3 (en) | Substituted benzimidazoles, preparation and use thereof as agents for the control of parasitic protozoa | |
| IS7539A (en) | Self-dispensing contraceptives from an oily solution. | |
| HN2002000355A (en) | PHARMACEUTICAL COMBINATION | |
| DK1420789T3 (en) | Use of active substances with myopioid receptor agonist and opioid receptor antagonist effect as combination drugs for cancer treatment | |
| HN2002000356A (en) | PHARMACEUTICAL COMBINATION | |
| HRP20050898A2 (en) | Glutamate receptor antagonists as neuroprotectives | |
| ATE333010T1 (en) | SANITARY CABIN |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |